Paula Eichenbrenner's first day on the job as the new executive director of the Myositis Association will be Nov.
29.
That's the day the rare muscle disorder, which causes inflammation and degeneration of the skeletal muscles, will be officially diagnosed.
Eichenbrenner, a Certified Association Executive (CAE) with a master's in business administration (MBA), has nearly 20 years of experience in nonprofit management, fundraising, advocacy, and health care, per a TMA press release.
"She brings a wealth of experience, skills, and passion to our organization and our mission," says David Mochel, MD, chair of TMA's board of directors.
"We are confident that she will lead TMA to new heights of success and service to our members and the myositis community."
Eichenbrenner comes to TMA from the Academy of Managed Care Pharmacy Foundation, where she served as executive director since 2015.
Under her leadership, the foundation "expanded its research and education programs, increased its visibility and impact, and strengthened its financial sustainability," per the press release.
Among Eichenbrenner's goals was "empowering patient voices related to prescription benefits and decision making about drugs," per the Virginian-Pilot.
A customized collection of grant news from foundations and the federal government from around the Web.
Here, five companies are marking their imprints to implement their corporate philanthropy goals. These companies are: Patagonia, Fuse Corps, Dow Corning, Warner Bros., and VeryNice.